Global Biopharmaceutical 3PL Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biopharmaceutical 3PL Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Cold Chain
  • 1.2.3 Non-cold Chain
• 1.3 Market by Application
  • 1.3.1 Global Biopharmaceutical 3PL Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Transportation
  • 1.3.3 Warehousing and Storage
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biopharmaceutical 3PL Market Perspective (2016-2027)
• 2.2 Biopharmaceutical 3PL Growth Trends by Regions
  • 2.2.1 Biopharmaceutical 3PL Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Biopharmaceutical 3PL Historic Market Share by Regions (2016-2021)
  • 2.2.3 Biopharmaceutical 3PL Forecasted Market Size by Regions (2022-2027)
• 2.3 Biopharmaceutical 3PL Industry Dynamic
  • 2.3.1 Biopharmaceutical 3PL Market Trends
  • 2.3.2 Biopharmaceutical 3PL Market Drivers
  • 2.3.3 Biopharmaceutical 3PL Market Challenges
  • 2.3.4 Biopharmaceutical 3PL Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biopharmaceutical 3PL Players by Revenue
  • 3.1.1 Global Top Biopharmaceutical 3PL Players by Revenue (2016-2021)
  • 3.1.2 Global Biopharmaceutical 3PL Revenue Market Share by Players (2016-2021)
• 3.2 Global Biopharmaceutical 3PL Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biopharmaceutical 3PL Revenue
• 3.4 Global Biopharmaceutical 3PL Market Concentration Ratio
  • 3.4.1 Global Biopharmaceutical 3PL Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical 3PL Revenue in 2020
• 3.5 Biopharmaceutical 3PL Key Players Head office and Area Served
• 3.6 Key Players Biopharmaceutical 3PL Product Solution and Service
• 3.7 Date of Enter into Biopharmaceutical 3PL Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical 3PL Breakdown Data by Type

• 4.1 Global Biopharmaceutical 3PL Historic Market Size by Type (2016-2021)
• 4.2 Global Biopharmaceutical 3PL Forecasted Market Size by Type (2022-2027)

5 Biopharmaceutical 3PL Breakdown Data by Application

• 5.1 Global Biopharmaceutical 3PL Historic Market Size by Application (2016-2021)
• 5.2 Global Biopharmaceutical 3PL Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Biopharmaceutical 3PL Market Size (2016-2027)
• 6.2 North America Biopharmaceutical 3PL Market Size by Type
  • 6.2.1 North America Biopharmaceutical 3PL Market Size by Type (2016-2021)
  • 6.2.2 North America Biopharmaceutical 3PL Market Size by Type (2022-2027)
  • 6.2.3 North America Biopharmaceutical 3PL Market Size by Type (2016-2027)
• 6.3 North America Biopharmaceutical 3PL Market Size by Application
  • 6.3.1 North America Biopharmaceutical 3PL Market Size by Application (2016-2021)
  • 6.3.2 North America Biopharmaceutical 3PL Market Size by Application (2022-2027)
  • 6.3.3 North America Biopharmaceutical 3PL Market Size by Application (2016-2027)
• 6.4 North America Biopharmaceutical 3PL Market Size by Country
  • 6.4.1 North America Biopharmaceutical 3PL Market Size by Country (2016-2021)
  • 6.4.2 North America Biopharmaceutical 3PL Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Biopharmaceutical 3PL Market Size (2016-2027)
• 7.2 Europe Biopharmaceutical 3PL Market Size by Type
  • 7.2.1 Europe Biopharmaceutical 3PL Market Size by Type (2016-2021)
  • 7.2.2 Europe Biopharmaceutical 3PL Market Size by Type (2022-2027)
  • 7.2.3 Europe Biopharmaceutical 3PL Market Size by Type (2016-2027)
• 7.3 Europe Biopharmaceutical 3PL Market Size by Application
  • 7.3.1 Europe Biopharmaceutical 3PL Market Size by Application (2016-2021)
  • 7.3.2 Europe Biopharmaceutical 3PL Market Size by Application (2022-2027)
  • 7.3.3 Europe Biopharmaceutical 3PL Market Size by Application (2016-2027)
• 7.4 Europe Biopharmaceutical 3PL Market Size by Country
  • 7.4.1 Europe Biopharmaceutical 3PL Market Size by Country (2016-2021)
  • 7.4.2 Europe Biopharmaceutical 3PL Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Biopharmaceutical 3PL Market Size (2016-2027)
• 8.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Type
  • 8.2.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Application
  • 8.3.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Biopharmaceutical 3PL Market Size by Region
  • 8.4.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Biopharmaceutical 3PL Market Size (2016-2027)
• 9.2 Latin America Biopharmaceutical 3PL Market Size by Type
  • 9.2.1 Latin America Biopharmaceutical 3PL Market Size by Type (2016-2021)
  • 9.2.2 Latin America Biopharmaceutical 3PL Market Size by Type (2022-2027)
  • 9.2.3 Latin America Biopharmaceutical 3PL Market Size by Type (2016-2027)
• 9.3 Latin America Biopharmaceutical 3PL Market Size by Application
  • 9.3.1 Latin America Biopharmaceutical 3PL Market Size by Application (2016-2021)
  • 9.3.2 Latin America Biopharmaceutical 3PL Market Size by Application (2022-2027)
  • 9.3.3 Latin America Biopharmaceutical 3PL Market Size by Application (2016-2027)
• 9.4 Latin America Biopharmaceutical 3PL Market Size by Country
  • 9.4.1 Latin America Biopharmaceutical 3PL Market Size by Country (2016-2021)
  • 9.4.2 Latin America Biopharmaceutical 3PL Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Biopharmaceutical 3PL Market Size (2016-2027)
• 10.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Type
  • 10.2.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Application
  • 10.3.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Biopharmaceutical 3PL Market Size by Country
  • 10.4.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 FedEx.
  • 11.1.1 FedEx. Company Details
  • 11.1.2 FedEx. Business Overview
  • 11.1.3 FedEx. Biopharmaceutical 3PL Introduction
  • 11.1.4 FedEx. Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.1.5 FedEx. Recent Development
• 11.2 DHL International GmbH
  • 11.2.1 DHL International GmbH Company Details
  • 11.2.2 DHL International GmbH Business Overview
  • 11.2.3 DHL International GmbH Biopharmaceutical 3PL Introduction
  • 11.2.4 DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.2.5 DHL International GmbH Recent Development
• 11.3 SF Express
  • 11.3.1 SF Express Company Details
  • 11.3.2 SF Express Business Overview
  • 11.3.3 SF Express Biopharmaceutical 3PL Introduction
  • 11.3.4 SF Express Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.3.5 SF Express Recent Development
• 11.4 United Parcel Service of America, Inc.
  • 11.4.1 United Parcel Service of America, Inc. Company Details
  • 11.4.2 United Parcel Service of America, Inc. Business Overview
  • 11.4.3 United Parcel Service of America, Inc. Biopharmaceutical 3PL Introduction
  • 11.4.4 United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.4.5 United Parcel Service of America, Inc. Recent Development
• 11.5 AmerisourceBergen Corporation
  • 11.5.1 AmerisourceBergen Corporation Company Details
  • 11.5.2 AmerisourceBergen Corporation Business Overview
  • 11.5.3 AmerisourceBergen Corporation Biopharmaceutical 3PL Introduction
  • 11.5.4 AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.5.5 AmerisourceBergen Corporation Recent Development
• 11.6 DB Schenker
  • 11.6.1 DB Schenker Company Details
  • 11.6.2 DB Schenker Business Overview
  • 11.6.3 DB Schenker Biopharmaceutical 3PL Introduction
  • 11.6.4 DB Schenker Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.6.5 DB Schenker Recent Development
• 11.7 KUEHNE + NAGEL
  • 11.7.1 KUEHNE + NAGEL Company Details
  • 11.7.2 KUEHNE + NAGEL Business Overview
  • 11.7.3 KUEHNE + NAGEL Biopharmaceutical 3PL Introduction
  • 11.7.4 KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.7.5 KUEHNE + NAGEL Recent Development
• 11.8 Kerry Logistics Network Limited
  • 11.8.1 Kerry Logistics Network Limited Company Details
  • 11.8.2 Kerry Logistics Network Limited Business Overview
  • 11.8.3 Kerry Logistics Network Limited Biopharmaceutical 3PL Introduction
  • 11.8.4 Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.8.5 Kerry Logistics Network Limited Recent Development
• 11.9 Agility
  • 11.9.1 Agility Company Details
  • 11.9.2 Agility Business Overview
  • 11.9.3 Agility Biopharmaceutical 3PL Introduction
  • 11.9.4 Agility Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.9.5 Agility Recent Development
• 11.10 EMS
  • 11.10.1 EMS Company Details
  • 11.10.2 EMS Business Overview
  • 11.10.3 EMS Biopharmaceutical 3PL Introduction
  • 11.10.4 EMS Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.10.5 EMS Recent Development
• 11.11 SF Express
  • 11.11.1 SF Express Company Details
  • 11.11.2 SF Express Business Overview
  • 11.11.3 SF Express Biopharmaceutical 3PL Introduction
  • 11.11.4 SF Express Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.11.5 SF Express Recent Development
• 11.12 Jd.Com, Inc.
  • 11.12.1 Jd.Com, Inc. Company Details
  • 11.12.2 Jd.Com, Inc. Business Overview
  • 11.12.3 Jd.Com, Inc. Biopharmaceutical 3PL Introduction
  • 11.12.4 Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2016-2021)
  • 11.12.5 Jd.Com, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer